{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T22:20:17Z","timestamp":1770502817616,"version":"3.49.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,8,26]],"date-time":"2007-08-26T00:00:00Z","timestamp":1188086400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1007\/s00592-007-0259-1","type":"journal-article","created":{"date-parts":[[2007,8,25]],"date-time":"2007-08-25T14:02:56Z","timestamp":1188050576000},"page":"167-169","source":"Crossref","is-referenced-by-count":22,"title":["A case of pegylated interferon alpha-related diabetic ketoacidosis: can this complication be avoided?"],"prefix":"10.1007","volume":"44","author":[{"given":"G.","family":"Tosone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Borgia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Cerini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. C. D.","family":"Conte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Orlando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Piazza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,8,26]]},"reference":[{"key":"259_CR1","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1046\/j.1464-5491.2001.00562.x","volume":"18","author":"M. Recasens","year":"2001","unstructured":"Recasens M, Aguilera E, Ampurdanes S, Sanchez Tapias JM, Simo O, Casamitjana R, Conget I (2001) Abrupt onset of diabetes during interferon-alpha therapy in patients with chronic hepatitis C. Diabet Med 18:764\u2013767","journal-title":"Diabet Med"},{"key":"259_CR2","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1046\/j.1365-2036.2003.01681.x","volume":"18","author":"P. Fabris","year":"2003","unstructured":"Fabris P, Floreani A, Tositti G, Vergani D, De Lalla F, Betterle C (2003) Review article: type 1 diabetes mellitus in patients with chronic hepatitis C before and after interferon therapy. Aliment Pharmacol Ther 18:549\u2013558","journal-title":"Aliment Pharmacol Ther"},{"key":"259_CR3","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1046\/j.1464-5491.2001.00492.x","volume":"18","author":"E. Bosi","year":"2001","unstructured":"Bosi E, Minelli R, Bazzigaluppi E, Salvi M (2001) Fulminant autoimmune type 1 diabetes during interferon-alpha therapy: a case of Th1-mediated disease? Diabet Med 18:329\u2013332","journal-title":"Diabet Med"},{"key":"259_CR4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0168-8227(00)00143-1","volume":"49","author":"H. Uto","year":"2000","unstructured":"Uto H, Matsuoka H, Murata M, Okamoto, T, Miyata Y, Hori T, Ido A, Hirono S, Hayashi K, Tsubouchi H (2000) A case of chronic hepatitis C developing insulin-dependent diabetes mellitus associated with various autoantibodies during interferon therapy. Diabetes Res Clin Pract 49:101\u2013106","journal-title":"Diabetes Res Clin Pract"},{"key":"259_CR5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.1365-2362.2000.00608.x","volume":"30","author":"T. Konrad","year":"2000","unstructured":"Konrad T, Zeuzem S, Vicini P, Toffolo G, Briem D, Lormann J, Hermann G, Berger A, Kusterer K, Teuber G, Cobelli C, Usadel KH (2000) Evaluation of factors controlling glucose tolerance in patients with HCV infection before and after 4 months therapy with interferon \u03b1. Eur J Clin Invest 30:111\u2013121","journal-title":"Eur J Clin Invest"},{"key":"259_CR6","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0210-5705(03)79089-X","volume":"27","author":"J. Primo Vera","year":"2004","unstructured":"Primo Vera J (2004) Pegylated-interferon-induced diabetes mellitus type 1 in two patients with chronic hepatitis C. Gastroenterol Hepatol 27:69","journal-title":"Gastroenterol Hepatol"},{"key":"259_CR7","first-page":"148","volume":"115","author":"F.I. Jabr","year":"2003","unstructured":"Jabr FI, Ordinario MM (2003) Sudden onset of diabetic ketoacidosis during pegylated interferon alfa therapy. Am J Med 115:148\u2013159","journal-title":"Am J Med"},{"key":"259_CR8","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1464-5491.2005.01412.x","volume":"22","author":"L.-K. Chen","year":"2005","unstructured":"Chen L-K, Chou Y-C, Tsait S-T, Hwang S-J, Lee S-D (2005) Hepatitis C virus infection-related type 1 diabetes mellitus. Diabet Med 22:340\u2013343","journal-title":"Diabet Med"},{"key":"259_CR9","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1055\/s-2004-824859","volume":"129","author":"M. Schories","year":"2004","unstructured":"Schories M, Peters T, Rasenack J, Reincke M (2004) Autoantibodies against islet cell antigens and type 1 diabetes after treatment with interferon-alpha. Dtsch Med Wochenschr 129:1120\u20131124","journal-title":"Dtsch Med Wochenschr"},{"key":"259_CR10","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.2337\/diacare.21.10.1774a","volume":"21","author":"G. Tohda","year":"1998","unstructured":"Tohda G, Oida K, Higashi S, Hayashi T, Miyamori I (1998) Interferon alfa and development of type 1 diabetes: a case without insulin resistance. Diabetes Care 21:1774","journal-title":"Diabetes Care"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-007-0259-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00592-007-0259-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-007-0259-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T03:45:14Z","timestamp":1559101514000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00592-007-0259-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,26]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["259"],"URL":"https:\/\/doi.org\/10.1007\/s00592-007-0259-1","relation":{},"ISSN":["0940-5429","1432-5233"],"issn-type":[{"value":"0940-5429","type":"print"},{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,26]]}}}